The Landscape of GLP-1 Prescriptions in Germany: A Comprehensive GuideThe pharmaceutical landscape in Germany has undergone a substantial shift over the last 2 years, driven largely by the global surge in need for GLP-1 (Glucagon-like peptide-1) receptor agonists. Originally established to treat Type 2 diabetes, these medications have gained worldwide
